RxDoctor Payments Data

Alisha Kumar

Pediatrics · Des Moines, IANPI 1225476310

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 109 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 8.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $491 and has fallen 69.5% since, to $150 in 2025. Among pediatrics clinicians in IA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,904in general payments, 2019–2025

Across 109 payments — averaging $17.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$156
  • Supernus Pharmaceuticals, Inc.$146
  • AbbVie$141
  • Takeda Pharmaceuticals U.S.A., Inc.$126
  • Novo Nordisk$122
  • Lilly USA, LLC$100
  • plus $1K from 28 others

What the payments were for

  • Food & beverage$1,904100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,904 in reported general payments places this provider in the 95th percentile of 308 pediatrics providers in Iowa.

See all pediatrics providers in Iowa

Other pediatrics in Des Moines

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →